Curia, a seasoned Contract Development and Manufacturing Organization (CDMO), is well-regarded for transforming innovative concepts into life-saving therapeutics, encapsulated by its slogan: "From curiosity to cure". With over 30 years in the industry, Curia combines its extensive experience with a global network of 25 sites and an expert team of 3,500 employees. These resources allow the company to offer a comprehensive suite of services spanning from drug discovery to commercialization, with strong integrated regulatory and analytical capabilities.
The company's proficiency in both biologics and small molecule offerings positions it as a reliable partner in the pharmaceutical landscape. Curia's commitment to leveraging state-of-the-art facilities and expert scientific processes highlights its dedication to delivering excellence in drug substance and product manufacturing, accelerating the development of life-changing therapeutics.
Investors should note the company's proactive stance against fraudulent employment activities, ensuring secure and authentic interactions via its official channels.